Subscribe for email alerts

Don’t miss a single Science & Enterprise post. Sign up for our daily email alerts.

Donate to Science & Enterprise

Please share Science & Enterprise

Nasal Spray Vaccines Get CEPI, NIH Funding

Nasal spray

A developer of infectious disease vaccines is gaining funds for new nasal sprays protecting against a range of coronaviruses and the sexually-transmitted disease gonorrhea. . . . → Read More: Nasal Spray Vaccines Get CEPI, NIH Funding

Infographic – Biotech Index Q3 Rollercoaster

NBI Year to date 30 Sept 2022

For the year-to-date, as noted in today’s chart, NBI shows a general decline, losing more than one-fifth of its value since January. . . . → Read More: Infographic – Biotech Index Q3 Rollercoaster

Start-Up Developing Efficient RNA Process, Raises $12M

Vials and bottles

A company formed earlier this year is commercializing a more efficient process for making synthetic RNA molecules and raising $12 million in seed funds. . . . → Read More: Start-Up Developing Efficient RNA Process, Raises $12M

NIH Funds Decentralized Rare Disease Data Network

Blockchain

A start-up company is building a secure decentralized network of genomic and other medical data on rare diseases, funded by a fast-track award from an NIH agency. . . . → Read More: NIH Funds Decentralized Rare Disease Data Network

Challenge Seeks Animal-Free Testing for Precision Meds.

Bioprinting

A charitable foundation promoting research on human longevity unveiled a challenge competition to develop animal-free testing for personalized medicine. . . . → Read More: Challenge Seeks Animal-Free Testing for Precision Meds.

Addiction Biotech Using Crowdfunding for Investments

Clock and coins graphic

A start-up enterprise developing treatments for drug and alcohol addiction is raising investment capital with a direct pitch to small investors through a crowdfunding platform. . . . → Read More: Addiction Biotech Using Crowdfunding for Investments

Eye Disease Gene-Therapy Biotech Adds Venture Funds

Monitor eyes

A biotechnology company designing treatments for inherited eye diseases with Crispr gene editing is raising €75 million in venture financing. . . . → Read More: Eye Disease Gene-Therapy Biotech Adds Venture Funds

Cell, mRNA Therapy Biotech Raises $165M in Early Funds

T-cells illustration

A new company, founded by university medical researchers, is developing cell therapies engineered with messenger RNA or mRNA to work inside the body. . . . → Read More: Cell, mRNA Therapy Biotech Raises $165M in Early Funds

Trial to Test Smart Watch to Guide Blood Thinners

Operating a smart watch

A clinical trial is planned to test heart rhythms measured with an Apple smart watch to guide use of blood thinning medicines in people with irregular heartbeat. . . . → Read More: Trial to Test Smart Watch to Guide Blood Thinners

Biotech Business Complex Slated for Colorado

38th Street in Boulder, CO

A developer backed by a life science/real estate joint venture announced plans to create a new campus for biotechnology and related businesses in Boulder, Colorado. . . . → Read More: Biotech Business Complex Slated for Colorado